The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
Open accessAbstract
Lipopolysaccharide (LPS) stimulation of the innate immune response requires the activation of signaling cascades that culminate in the synthesis and secretion of proinflammatory cytokines. Given the inhibitory effects of phosphodiesterase (PDE) inhibitors on LPS-induced cytokine production, we have investigated LPS responses in mice deficient in PDE4 (type 4 cAMP-specific PDE)-B and PDE4D. LPS stimulation of mouse peripheral leukocytes induced PDE4B mRNA accumulation and increased PDE4 activity. This response was completely absent in mice deficient in PDE4B but not PDE4D. LPS induction of tumor necrosis factor-α secretion by circulating leukocytes was decreased by approximately 90% in mice deficient in PDE4B but not in mice lacking PDE4D. The impaired LPS response was evident regardless of the LPS dose used for stimulation and was associated with a more than 90% decrease in tumor necrosis factor-α mRNA accumulation. A decreased responsiveness to LPS was also present in other inflammatory cells, including peritoneal and lung macrophages. These findings demonstrate that PDE4B gene activation by LPS constitutes a feedback regulation essential for an efficient immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
LPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,304
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., & Cerami, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1670 · Cited by 1,516
Rat Insulin Genes: Construction of Plasmids Containing the Coding Sequences
Ullrich, A., Shine, J., Chirgwin, J., Pictet, R., Tischer, E., Rutter, W. J., & Goodman, H. M. (1977) · Science · doi:10.1126/science.325648 · Cited by 1,238
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,217
Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.269 · Cited by 743
Thompson, G. A., Bambery, R. J., & Nozawa, Y. (1971) · Biochemistry · doi:10.1021/bi00800a014 · Cited by 674
Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences
Wilson, T., & Treisman, R. (1988) · Nature · doi:10.1038/336396a0 · Cited by 669
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.
Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., & Remick, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60727-6 · Cited by 661
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Toll signaling pathways in the innate immune response
Anderson, K. V. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00045-x · Cited by 632
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline
Strieter, R. M., Remick, D. G., Ward, P. A., Spengler, R. N., Lynch, J. P., Larrick, J., & Kunkel, S. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81271-3 · Cited by 561
Han, J., Thompson, P., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.391 · Cited by 508
Han, J., Brown, T., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.465 · Cited by 477
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs
de Rooij, J., Rehmann, H., van Triest, M., Cool, R. H., Wittinghofer, A., & Bos, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001113200 · Cited by 398
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease
Stack, W., Mann, S., Roy, A., Heath, P., Sopwith, M., Freeman, J., Holmes, G., Long, R., Forbes, A., Kamm, M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80083-9 · Cited by 384
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
Translational Blockade Imposed by Cytokine-Derived UA-Rich Sequences
Kruys, V., Marinx, O., Shaw, G., Deschamps, J., & Huez, G. (1989) · Science · doi:10.1126/science.2672333 · Cited by 330
Houslay, M. D., Sullivan, M., & Bolger, G. B. (1998) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60128-3 · Cited by 290
(1999) · PubMed · Cited by 277
CD3- and CD28-Dependent Induction of PDE7 Required for T Cell Activation
Li, L., Yee, C., & Beavo, J. A. (1999) · Science · doi:10.1126/science.283.5403.848 · Cited by 259
Introduction: The role of innate immunity in the adaptive immune response
Janeway Jr., C. A., & Medzhitov, R. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0142 · Cited by 243
Collart, M. A., Baeuerle, P., & Vassalli, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498-1506.1990 · Cited by 235
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
Jin, S.-L. C., Richard, F. J., Kuo, W.-P., D’Ercole, A. J., & Conti, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11998 · Cited by 232
Self-citationDrouet, C., Shakhov, A. N., & Jongeneel, C. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1694 · Cited by 216
Fekade, D., Knox, K., Hussein, K., Melka, A., Lalloo, D. G., Coxon, R. E., & Warrell, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608013350503 · Cited by 198
Eigler, A., Siegmund, B., Emmerich, U., Baumann, K. H., Hartmann, G., & Endres, S. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.1.101 · Cited by 187
Wang, P., Wu, P., Ohleth, K. M., Egan, R. W., & Billah, M. M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26397-5 · Cited by 173
Raabe, T., Bukrinsky, M., & Currie, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.974 · Cited by 171
Evaluation of CD14 in host defence
Antal‐Szalmás (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00610.x · Cited by 152
Verghese, M. W., McConnell, R. T., Strickland, A. B., Gooding, R. C., Stimpson, S. A., Yarnall, D. P., Taylor, J. D., & Furdon, P. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24562-1 · Cited by 136
Prabhakar, U., Lipshutz, D. B., Bartus, J. O., Slivjak, M. J., Smith, E. F., Lee, J. C., & Esser, K. M. (1994) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)90054-x · Cited by 135
Gating by Cyclic AMP: Expanded Role for an Old Signaling Pathway
Iyengar, R. (1996) · Science · doi:10.1126/science.271.5248.461 · Cited by 135
Swinnen, J. V., Tsikalas, K. E., & Conti, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55280-7 · Cited by 128
Self-citationSpengler, R. N., Spengler, M. L., Lincoln, P., Remick, D. G., Strieter, R. M., & Kunkel, S. L. (1989) · Infection and Immunity · doi:10.1128/iai.57.9.2837-2841.1989 · Cited by 119
Souness, J. E., Griffin, M., Maslen, C., Ebsworth, K., Scott, L. C., Pollock, K., Palfreyman, M. N., & Karlsson, J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15450.x · Cited by 114
Beutler, B., & Kruys, V. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199500252-00002 · Cited by 106
Antibodies to tumour necrosis factor α as treatment for Crohn's disease
Bell, S., & Kamm, M. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)00442-0 · Cited by 99
Torphy, T. J., Zhou, H.-L., Foley, J. J., Sarau, H. M., Manning, C. D., & Barnette, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23598 · Cited by 90
Sinha, B. N. M., Semmler, J., Eisenhut, T., Eigler, A., & Endres, S. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250125 · Cited by 80
Yoshimura, T., Kurita, C., Nagao, T., Usami, E., Nakao, T., Watanabe, S., Kobayashi, J., Yamazaki, F., Tanaka, H., & Nagai, H. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00580-0 · Cited by 76
Schade, F. U., & Schudt, C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90403-5 · Cited by 61
Cited by
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Self-citationLugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Metadata
- Authors
- Jin, S.-L. C., & Conti, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-05-21
- Volume
- 99
- Issue
- 11
- Pages
- 7628-7633
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2159269771
- Cited by
- 367
- References
- 48
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.